ADVENZYMES
Advanced Enzyme Technologies Limited (ADVENZYMES) Stock Analysis
Advanced Enzyme Technologies Limited is an Indian biotechnology company manufacturing industrial enzymes and probiotics. Its enzymes are used in food, animal nutrition, baking, brewing, and household applications globally. The company exports to many countries from R&D and manufacturing facilities in India. It is a listed specialty biotech company.
Basic Materials › Specialty Chemicals
₹292.80
+1.61% 1W | -11.40% 52W
Market Cap
3.2k CR
P/E Ratio
19.8
52W High
₹419
52W Low
₹251.9
Div. Yield
0.86%
Beta
0.7
50 DMA
₹305.3
200 DMA
₹313.3
Profit Margin
22.1%
Inst. Own.
19.3%
🔥 APPROACHING RESISTANCE
🔥 APPROACHING RESISTANCE
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 147 | 158 | 161 | 158 | 155 | 146 | 169 | 167 | 186 | 185 | 172 | 203 | 190 |
| Expenses | 103 | 107 | 107 | 102 | 103 | 104 | 114 | 122 | 129 | 124 | 123 | 140 | 139 |
| Operating Profit | 44 | 51 | 54 | 55 | 51 | 42 | 55 | 46 | 56 | 60 | 49 | 63 | 51 |
| OPM % | 30% | 32% | 33% | 35% | 33% | 29% | 33% | 27% | 30% | 33% | 29% | 31% | 27% |
| Other Income | 7 | 6 | 14 | -6 | 7 | 10 | 8 | 9 | 9 | 10 | 20 | 7 | 13 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 10 | 10 |
| Profit before tax | 41 | 48 | 59 | 40 | 49 | 42 | 53 | 43 | 55 | 60 | 58 | 60 | 54 |
| Tax % | 29% | 27% | 28% | 25% | 28% | 21% | 27% | 38% | 26% | 25% | 26% | 24% | 28% |
| Net Profit | 29 | 35 | 42 | 30 | 35 | 33 | 39 | 27 | 40 | 45 | 43 | 45 | 39 |
| EPS in Rs | 2.58 | 3.08 | 3.74 | 2.53 | 3.05 | 2.94 | 3.37 | 2.37 | 3.57 | 3.87 | 3.80 | 3.84 | 3.31 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 222 | 293 | 329 | 391 | 420 | 444 | 502 | 529 | 541 | 624 | 637 | 746 | 750 |
| Expenses | 131 | 155 | 177 | 226 | 236 | 241 | 269 | 327 | 382 | 418 | 441 | 515 | 526 |
| Operating Profit | 91 | 138 | 152 | 165 | 184 | 203 | 232 | 203 | 158 | 206 | 196 | 230 | 224 |
| OPM % | 41% | 47% | 46% | 42% | 44% | 46% | 46% | 38% | 29% | 33% | 31% | 31% | 30% |
| Other Income | 1 | -3 | 3 | 1 | 5 | 6 | 9 | 6 | 21 | 21 | 33 | 46 | 50 |
| Interest | 9 | 8 | 4 | 9 | 5 | 4 | 3 | 3 | 3 | 4 | 5 | 4 | 2 |
| Depreciation | 9 | 9 | 13 | 18 | 21 | 26 | 28 | 35 | 35 | 35 | 37 | 40 | 40 |
| Profit before tax | 74 | 118 | 137 | 139 | 162 | 179 | 210 | 171 | 140 | 188 | 187 | 233 | 231 |
| Tax % | 31% | 35% | 32% | 33% | 28% | 26% | 28% | 28% | 26% | 27% | 28% | 25% | |
| Net Profit | 51 | 77 | 93 | 94 | 116 | 133 | 151 | 124 | 104 | 137 | 134 | 174 | 172 |
| EPS in Rs | 4.60 | 6.97 | 8.20 | 8.07 | 9.95 | 11.58 | 13.09 | 10.70 | 9.45 | 11.92 | 11.72 | 15.07 | 14.82 |
| Dividend Payout % | 4% | 3% | 5% | 6% | 6% | 5% | 7% | 9% | 11% | 43% | 44% | 36% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 11.0% | 8.0% | 10.0% |
| Profit CAGR | 12.0% | 1.0% | 7.0% |
Shareholding Pattern
Promoters43.08%
FIIs23.45%
DIIs8.45%
Public25.00%
Promoters43.08%
FIIs25.41%
DIIs6.41%
Public25.09%
Promoters43.04%
FIIs25.85%
DIIs5.51%
Public25.62%
Promoters43.26%
FIIs25.50%
DIIs5.41%
Public25.85%
Promoters43.25%
FIIs26.70%
DIIs4.77%
Public25.28%
Promoters49.88%
FIIs21.86%
DIIs5.73%
Public22.54%
Promoters43.50%
FIIs23.01%
DIIs7.56%
Public25.95%
Promoters43.08%
FIIs11.90%
DIIs8.19%
Public36.82%
Promoters43.26%
FIIs25.50%
DIIs5.41%
Public25.85%
Promoters43.25%
FIIs26.70%
DIIs4.77%
Public25.28%
ADVENZYMES
Holdings Analysis
Key strengths & risk signals
66
Overall
78
Fundamental
54
Technical
Risks (4)
NEGLIGIBLE DIVIDEND! 0.87% yield - little to no income.
WEAK POSITION! Current price (297.0) is below both moving averages.
WEAK YEAR! Stock declined 12.1% in the last year.
BEARISH TREND! 50-day average (305.8) is below 200-day average (313.3) - negative signal.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BREAKOUT! Stock has broken above resistance levels with momentum.
LOW VOLATILITY! Beta of 0.70 - stable stock, less market risk.
NEUTRAL! RSI at 47.6 - balanced momentum.
Fundamental & Technical Analysis
61Overall
78Fundamental
44Technical
Fundamental Breakdown
Growth Quality
24/30
Revenue CAGR: 11.3% (GOOD, 11/15). Profit CAGR: 16.9% (VERY GOOD, 13/15).
Profit Margin
8/10
EXCELLENT EFFICIENCY! 22.1% profit margin - company keeps strong profits.
PEG Valuation
9/10
FAIRLY VALUED! PEG of 1.17 indicates reasonable valuation.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.86% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
14/20
MODERATE PUBLIC HOLDING! 24.02% public ownership - balanced ownership structure.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
3/10
BEARISH TREND! 50-day average (305.3) is below 200-day average (313.3) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (292.8) is below both moving averages.
Trend Pattern
10/20
AT RESISTANCE! Stock is at key resistance level.
52W Performance
2/10
WEAK YEAR! Stock declined 11.4% in the last year.
Volume Sentiment
15/30
BEARISH SENTIMENT! In last 30 days: 17 up days, 13 down days. Avg volume on up days: 243,009 vs down days: 276,135. Ratio: 0.88x
RSI
3/5
NEUTRAL! RSI at 43.4 - balanced momentum.
52W Range
2/5
LOWER HALF! Trading at 24.5% of 52W range - weakness visible.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - 1.6% (1 week), -2.3% (1 month), -16.0% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.70 - stable stock, less market risk.
ADVENZYMES
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-05-15 | Concall PDF | |
| Q3FY262026-02-07 | Concall PDF | |
| Q2FY262025-11-17 | Concall PDF |
Peer Comparison
Basic Materials · Specialty Chemicals · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADVENZYMES | ₹292.80 | 19.8 | 22.1% | 11.3% | 16.9% | -11.4% | 61 | APPROACHING RESISTANCE | -7.0% | -13.7% | +2.1% | -6.7% |
| NOCIL | ₹191.40 | 48.6 | 4.8% | -7.4% | -28.0% | +14.0% | 55 | APPROACHING SUPPORT | +60.7% | +63.5% | +19.9% | +22.0% |
| APCOTEXIND | ₹602.90 | 19.4 | 10.1% | 10.1% | -2.1% | +50.2% | 56 | APPROACHING SUPPORT | +310.9% | +127.4% | +39.9% | +32.2% |
| JUBLCPL | ₹2,160.30 | 25.6 | 6.6% | 22.8% | 107.4% | -14.0% | 77 | BREAKDOWN | +4.5% | +131.7% | +18.2% | +7.8% |
| XPROINDIA | ₹1,207.00 | 85.1 | 6.1% | -0.1% | -24.9% | +0.1% | 51 | CONSOLIDATING DOWN | -243.6% | -39.2% | +20.4% | +29.8% |
| POLYPLEX | ₹1,097.40 | 22.2 | 2.0% | -2.5% | -49.5% | +0.2% | 53 | BREAKDOWN | -571.5% | +266.9% | +29.6% | +20.5% |
| KIRIINDUS | ₹559.90 | 0.6 | 615.5% | -3.6% | 273.7% | -2.5% | 77 | CONSOLIDATING UP | +2,773.3% | -43.6% | +54.6% | +24.7% |
| POCL | ₹468.90 | 25.9 | 4.3% | 25.3% | 20.7% | -3.2% | 60 | BREAKOUT | +42.5% | -4.3% | +55.1% | 0.0% |
Data from TradeAlone · Updated daily
ADVENZYMES News
Advanced Enzyme Technologies Limited (ADVENZYMES) falls 5% intraday backed by Q1 FY27 results2026-08-10Advanced Enzyme Technologies Limited Q1 FY27: Revenue Up 2%, PAT Down 5%2026-08-08Advanced Enzyme Technologies Limited (NSE: ADVENZYMES) gains 7% intraday2026-08-03Advanced Enzyme Technologies Limited (ADVENZYMES) falls 6% intraday, breaks below support2026-06-30Advanced Enzyme Technologies Limited (NSE: ADVENZYMES) breaks below support, falls 5% intraday2026-06-29Advanced Enzyme Technologies Limited (NSE: ADVENZYMES) breaks below support, moves down 6%2026-06-25Advanced Enzyme Technologies Reports Strong Q4 FY26 Results2026-05-09
